Tsuge I - Search Results

1

Prospective monitoring of the Epstein-Barr virus DNA by a real-time quantitative polymerase chain reaction after allogenic stem cell transplantation.

Hoshino Y, Kimura H, Tanaka N, Tsuge I, Kudo K, Horibe K, Kato K, Matsuyama T, Kikuta A, Kojima S, Morishima T. Hoshino Y, et al. Among authors: tsuge i. Br J Haematol. 2001 Oct;115(1):105-11. doi: 10.1046/j.1365-2141.2001.03087.x. Br J Haematol. 2001. PMID: 11722419 Free article.

2

Quantitative analysis of cytomegalovirus load using a real-time PCR assay.

Tanaka N, Kimura H, Iida K, Saito Y, Tsuge I, Yoshimi A, Matsuyama T, Morishima T. Tanaka N, et al. Among authors: tsuge i. J Med Virol. 2000 Apr;60(4):455-62. doi: 10.1002/(sici)1096-9071(200004)60:4<455::aid-jmv14>3.0.co;2-q. J Med Virol. 2000. PMID: 10686030

3

Longitudinal dynamics of Epstein-Barr virus-specific cytotoxic T lymphocytes during posttransplant lymphoproliferative disorder.

Kuzushima K, Kimura H, Hoshino Y, Yoshimi A, Tsuge I, Horibe K, Morishima T, Tsurumi T, Kojima S. Kuzushima K, et al. Among authors: tsuge i. J Infect Dis. 2000 Sep;182(3):937-40. doi: 10.1086/315791. Epub 2000 Aug 10. J Infect Dis. 2000. PMID: 10950793

4

Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T. Kimura H, et al. Among authors: tsuge i. Blood. 2001 Jul 15;98(2):280-6. doi: 10.1182/blood.v98.2.280. Blood. 2001. PMID: 11435294 Free article.

5

Vidarabine therapy for severe chronic active Epstein-Barr virus infection.

Kimura H, Morita M, Tsuge I, Hoshino Y, Tanaka N, Ito Y, Morishima T. Kimura H, et al. Among authors: tsuge i. J Pediatr Hematol Oncol. 2001 Jun-Jul;23(5):294-9. doi: 10.1097/00043426-200106000-00012. J Pediatr Hematol Oncol. 2001. PMID: 11464986

6

Clonal haematopoiesis in children with acquired aplastic anaemia.

Tsuge I, Kojima S, Matsuoka H, Abe T, Kamachi Y, Torii S, Matsuyama T. Tsuge I, et al. Br J Haematol. 1993 May;84(1):137-43. doi: 10.1111/j.1365-2141.1993.tb03036.x. Br J Haematol. 1993. PMID: 8338766

7

Characterization of Epstein-Barr virus (EBV)-infected natural killer (NK) cell proliferation in patients with severe mosquito allergy; establishment of an IL-2-dependent NK-like cell line.

Tsuge I, Morishima T, Morita M, Kimura H, Kuzushima K, Matsuoka H. Tsuge I, et al. Clin Exp Immunol. 1999 Mar;115(3):385-92. doi: 10.1046/j.1365-2249.1999.00836.x. Clin Exp Immunol. 1999. PMID: 10193407 Free PMC article.

8

Impaired cytotoxic T lymphocyte response to Epstein-Barr virus-infected NK cells in patients with severe chronic active EBV infection.

Tsuge I, Morishima T, Kimura H, Kuzushima K, Matsuoka H. Tsuge I, et al. J Med Virol. 2001 Jun;64(2):141-8. doi: 10.1002/jmv.1029. J Med Virol. 2001. PMID: 11360246

9

Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection.

Kimura H, Tsuge I, Imai S, Yamamoto M, Kuzushima K, Osato T, Morishima T. Kimura H, et al. Among authors: tsuge i. Med Microbiol Immunol. 1995 Aug;184(2):63-8. doi: 10.1007/BF00221388. Med Microbiol Immunol. 1995. PMID: 7500912

10

Establishment of anti-Epstein-Barr virus (EBV) cellular immunity by adoptive transfer of virus-specific cytotoxic T lymphocytes from an HLA-matched sibling to a patient with severe chronic active EBV infection.

Kuzushima K, Yamamoto M, Kimura H, Ando Y, Kudo T, Tsuge I, Morishima T. Kuzushima K, et al. Among authors: tsuge i. Clin Exp Immunol. 1996 Feb;103(2):192-8. doi: 10.1046/j.1365-2249.1996.d01-619.x. Clin Exp Immunol. 1996. PMID: 8565299 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters